12:00 AM
Sep 17, 2012
 |  BC Week In Review  |  Company News  |  Sales & Marketing

Eisai sales and marketing update

Eisai launched Fycompa perampanel in the U.K. as an adjunctive therapy for partial-onset seizures in epilepsy patients 12 years...

Read the full 81 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >